Technology
Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and – GlobeNewswire
Works against mutant strains including DeltaNo need for refrigeration during transport and storage No added stabilisers or chemicals…
- Works against mutant strains including Delta
- No need for refrigeration during transport and storage
- No added stabilisers or chemicals
- Safety and immune response clinical trial recruiting now in Melbourne
- Efficacy trial planned for USA
SYDNEY and NEW YORK,…
Continue Reading